Bristol-Myers Squibb Co. and Sanofi-Aventis SA have recalled about 64 million tablets of hypertension drug Avalide because a manufacturing problem could affect the drug’s efficacy.
It is the second significant recall of Avalide in recent months. In September, Bristol and Sanofi recalled about 60 million tablets. Get the full story »
